Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!
SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
论文查重
登录
注册
发布文献求助
首页
我的求助
捐赠本站
首乌
Lv7
4880 积分
2023-03-27 加入
最近求助
最近应助
互助留言
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
9天前
已完结
Osimertinib in ResectedEGFR-Mutated Non–Small-Cell Lung Cancer
9天前
已完结
中国药物性肝损伤诊治指南(2023年版)
13天前
已完结
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
16天前
已完结
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer
16天前
已完结
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial
1个月前
已完结
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
2个月前
已完结
没有进行任何应助
感谢,点赞,帮大忙了,么么哒
9天前
感谢,点赞,速度真快,么么哒
9天前
感谢,点赞,速度真快,帮大忙了,么么哒
13天前
感谢,速度真快,帮大忙了,么么哒
16天前
感谢,速度真快,帮大忙了,么么哒
16天前
感谢,点赞,速度真快,帮大忙了
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论